$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cyclodextrin mediated controlled release of edaravone from pH-responsive sodium alginate and chitosan based nanocomposites

International journal of biological macromolecules, v.202, 2022년, pp.11 - 25  

Khushbu (Corresponding author.) ,  Jindal, Rajeev

Abstract AI-Helper 아이콘AI-Helper

Abstract The objective of the study is to enhance the aqueous solubility and stability of edaravone, a free radical scavenger drug. Inclusion complexes of edaravone with β-cyclodextrin were prepared by microwave irradiation and physical mixture method and confirmation of inclusion complexes we...

주제어

참고문헌 (39)

  1. RSC Adv. Jafarbeglou 6 50002 2016 10.1039/C6RA03942A Clay nanocomposites as engineered drug delivery systems 

  2. Clay Miner. Hosseini 53 53 2018 10.1180/clm.2018.4 Bentonite nanoclay-based drug-delivery systems for treating melanoma 

  3. Bull. Mater. Sci. Patel 29 133 2006 10.1007/BF02704606 Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment 

  4. J. Solid State Chem. Wei 177 2534 2004 10.1016/j.jssc.2004.03.041 Studies on the intercalation of naproxen into layered double hydroxide and its thermal decomposition by in situ FT-IR and in situ HT-XRD 

  5. Int. J. Biol. Macromol. Zia 49 1131 2011 10.1016/j.ijbiomac.2011.09.010 Cytotoxicity and mechanical behavior of chitin-bentonite clay based polyurethane bio-nanocomposites 

  6. J. Appl. Polym. Sci. Lee 91 2934 2004 10.1002/app.13499 Effect of bentonite on the physical properties and drug-release behavior of poly(AA-co-PEGMEA)/bentonite nanocomposite hydrogels for mucoadhesive 

  7. ACS Omega Zhang 2020 Structure regulation of bentonite-alginate nanocomposites for controlled release of imidacloprid 

  8. Appl. Clay Sci. Singh 47 384 2010 10.1016/j.clay.2009.12.001 Controlled release of thiram from neem-alginate-clay based delivery systems to manage environmental and health hazards 

  9. Int. J. Biol. Macromol. Kumar 81 631 2015 10.1016/j.ijbiomac.2015.08.062 Development and evaluation of alginate-chitosan nanocapsules for controlled release of acetamiprid 

  10. Int. J. Biol. Macromol. Liang 112 258 2018 10.1016/j.ijbiomac.2018.01.174 Chitosan-based nanoparticles of avermectin to control pine wood nematodes 

  11. J. Drug Deliv. Sci. Technol. Khushbu 61 2021 RSM-CCD optimized microwave assisted synthesis of chitosan and sodium alginate based nanocomposite containing inclusion complexes of β-cyclodextrin and amlodipine besylate for sustained drug delivery systems 

  12. ACS Appl. Mater. Interfaces Sheng 7 15430 2015 10.1021/acsami.5b03555 N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption 

  13. Jindal 2021 Comparative Evaluation for Controlled Release of Amoxicillin From RSM-CCD-optimized Nanocomposites Based on Sodium Alginate and Chitosan-containing Inclusion Complexes 

  14. Molecules Li 23 1 2018 Chitosan-based nanomaterials for drug delivery 

  15. ACS Appl. Mater. Interfaces Hardy 10 29347 2018 10.1021/acsami.8b09733 β-Cyclodextrin-functionalized chitosan/alginate compact polyelectrolyte complexes (CoPECs) as functional biomaterials with anti-inflammatory properties 

  16. Pharmaceutics Mohammed 9 2017 10.3390/pharmaceutics9040053 An overview of chitosan nanoparticles and its application in non-parenteral drug delivery 

  17. Front. Bioeng.Biotechnol. Saeed 8 1 2020 10.3389/fbioe.2020.00004 Stable chitosan-based nanoparticles using polyphosphoric acid or hexametaphosphate for tandem ionotropic/covalent crosslinking and subsequent investigation as novel vehicles for drug delivery 

  18. Int. J. Biol. Macromol. Hejjaji 120 1610 2018 10.1016/j.ijbiomac.2018.09.185 Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios 

  19. J.Drug Deliv. Sci.Technol. Kaur 48 161 2018 10.1016/j.jddst.2018.09.003 RSM-CCD optimized microwave-assisted synthesis of chitosan and gelatin-based pH sensitive, inclusion complexes incorporated hydrogels and their use as controlled drug delivery systems 

  20. J. Mater. Chem. B Flynn 8 4029 2020 10.1039/D0TB00169D Tuning the strength and swelling of an injectable polysaccharide hydrogel and the subsequent release of a broad spectrum bacteriocin, nisin A 

  21. Curr. Drug Deliv. Giri 9 539 2012 10.2174/156720112803529800 Alginate based hydrogel as a potential biopolymeric carrier for drug delivery and cell delivery systems: present status and applications 

  22. J. Biol. Engineering. Abasalizadeh 14 1 2020 Erratum: Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting (Journal of Biological Engineering (2020) 14: 8 DOI: 10.1186/s13036-020-0227-7) 

  23. Biofabrication Decante 13 2021 10.1088/1758-5090/abec2c Engineering bioinks for 3D bioprinting 

  24. Adv. Pharmacol.Pharm. Sci. Hariyadi 2020 2020 Current status of alginate in drug delivery 

  25. Mater. Sci. Eng. C Serafin 122 2021 10.1016/j.msec.2021.111927 Printable alginate/gelatin hydrogel reinforced with carbon nanofibers as electrically conductive scaffolds for tissue engineering 

  26. Transplant. Proc. Nakamura 40 2171 2008 10.1016/j.transproceed.2008.06.049 A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from non-heart-beating donors 

  27. Int. J. Pharm. Sato 372 33 2009 10.1016/j.ijpharm.2008.12.038 A novel administration route for edaravone: I. Effects of metabolic inhibitors on skin permeability of edaravone 

  28. J. Cardiol. Nakamura 54 416 2009 10.1016/j.jjcc.2009.07.001 The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction 

  29. Heart Vessel. Yamazaki 24 228 2009 10.1007/s00380-008-1106-1 Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart 

  30. Carbohydr. Polym. Zeng 83 1101 2011 10.1016/j.carbpol.2010.09.007 Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-β-cyclodextrin 

  31. Biol. Eng. Med. Cheirsilp 2 1 2017 10.15761/BEM.1000108 Inclusion complex formation of cyclodextrin with its guest and their applications 

  32. Process Biochem. Del Valle 39 1033 2004 10.1016/S0032-9592(03)00258-9 Cyclodextrins and their uses: a review 

  33. Polym. Bull. Kaur 76 3569 2019 10.1007/s00289-018-2555-z Exploring RSM-CCD-optimized chitosan-/gelatin-based hybrid polymer network containing CPM-β-CD inclusion complexes as controlled drug delivery systems 

  34. Sci. Rep. Saha 6 1 2016 10.1038/srep35764 Study to explore the mechanism to form inclusion complexes of β-cyclodextrin with vitamin molecules 

  35. Beilstein J. Org. Chem. Fifere 8 2191 2012 10.3762/bjoc.8.247 Theoretical study on β-cyclodextrin inclusion complexes with propiconazole and protonated propiconazole 

  36. journal of developingDrugs Baishya 06 1 2017 Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets 

  37. Chem. Rev. Connors 97 1325 1997 10.1021/cr960371r The stability of cyclodextrin complexes in solution 

  38. A Simple Equation for Description of Solute Release Ritger 5 37 1987 

  39. Int. J. Pharm. Loftsson 302 18 2005 10.1016/j.ijpharm.2005.05.042 Evaluation of cyclodextrin solubilization of drugs 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로